Explores quantitative proteome profiling for drug target identification through activity-based protein profiling and advanced mass spectrometry techniques.
Explores transition metal oxides as OER catalysts, focusing on active sites in Fe-free and Fe-doped Ni oxides, revealing insights into the OER mechanism.
